Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2015-04-24

Clinical Trial Update: Efficacy Trial of Zonisamide for Myoclonus Dystonia [Phase 3]

View source ↗

Summary

Clinical trial update indicates the Phase 3 efficacy trial of zonisamide for myoclonus-dystonia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Zonisamide (zonisamide)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Myoclonus Dystonia | Phase 3 | Status: COMPLETED